Referral to endocrinology is appropriate for complex cases, inadequate response, or significant adverse effects
The ASCO Post
Gallbladder Disease: Increased risk of gallstones, especially in individuals with existing gallbladder problems
In research involving combined (synergistic) exposure, results suggest that Ipamorelins receptor-mediated activity is observed earlier in the response profile, potentially priming GH release
Juan Manuel Perics has also received personal fees, mainly travel support, from Boehringer-Ingelheim, Madrigal, NovoNordisk, MSD and Novartis outside the submitted work
GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them